Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $5 | $5 | $5 | $4 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $4 | $4 | $4 | $4 |
| Enterprise Value | $8 | $8 | $7 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.038 | -0.082 | -0.08 | -0.089 |
| % Growth | 53.2% | -2.4% | 10.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |